Markets:

Overview

News

Currencies

International

Treasuries

JELD-WEN Holding, Inc. Common Stock (NY:JELD)

1.740 +0.140 (+8.75%)

Streaming Delayed Price Updated: 3:50 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about JELD-WEN Holding, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Where JELD-WEN Holding Stands With Analysts ↗

October 17, 2023

Via Benzinga

Where JELD-WEN Holding Stands With Analysts ↗

August 09, 2023

Via Benzinga

JELD-WEN Likely To Post Lower Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts ↗

August 07, 2023

JELD-WEN Holding, Inc. (NYSE: JELD) is expected to report its second quarter financial results, after the closing bell on Aug. 7, 2023.

Via Benzinga

JELD-WEN Holding's Earnings Outlook ↗

August 04, 2023

Via Benzinga

The Latest Analyst Ratings for JELD-WEN Holding ↗

July 13, 2023

Via Benzinga

JELD-WEN Divests Australasia Business To Platinum Equity ↗

July 03, 2023

JELD-WEN Holding, Inc. (NYSE: JELD) completed the previously announced

Via Benzinga

Why Jeld-Wen Stock Is Up Big This Week ↗

May 11, 2023

A surprisingly strong quarter suggests the company is holding up well in a tough environment.

Via The Motley Fool

6 Analysts Have This to Say About JELD-WEN Holding ↗

February 22, 2023

Via Benzinga

Looking Into JELD-WEN Holding's Return On Capital Employed ↗

February 22, 2023

Via Benzinga

Why Jeld-Wen Stock Is Up Today ↗

February 21, 2023

The construction products company showed its resilience in a better-than-expected quarter.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About JELD-WEN Holding ↗

December 20, 2022

Via Benzinga

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday ↗

May 09, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

JELD-WEN Holding: Q3 Earnings Insights ↗

October 31, 2022

JELD-WEN Holding (NYSE:JELD) reported its Q3 earnings results on Monday, October 31, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

JELD-WEN stock: When Execution Counts

February 22, 2023

JELD-WEN had a better-than-expected quarter and is giving favorable guidance, but the growth outlook is not there and share prices will reflect this in 2023.

Via MarketBeat

Alcoa To Rally Over 35%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

February 22, 2023

Barclays boosted the price target for Bath & Body Works Inc (NYSE: BBWI) from $39 to $43. Barclays analyst Adrienne Yih maintained an Equal-Weight rating on the stock. Bath & Body Works shares fell 5%...

Via Benzinga

Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday ↗

February 21, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 450 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

20 Undervalued Stocks to Buy Under $20 ↗

February 08, 2023

Investors looking for profit and protection in 2023 can strike it rich with these 20 undervalued stocks to buy right now.

Via InvestorPlace

What 6 Analyst Ratings Have To Say About JELD-WEN Holding ↗

October 14, 2022

Within the last quarter, JELD-WEN Holding (NYSE:JELD) has observed the following analyst ratings:

Via Benzinga

3 Stocks Insiders Are Buying: Triumph Financial And More ↗

February 01, 2023

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022 ↗

December 20, 2022

Via Benzinga

Looking Into JELD-WEN Holding's Return On Capital Employed ↗

November 07, 2022

JELD-WEN Holding (NYSE:JELD) brought in sales totaling $1.30 billion during Q3 according to data provided by Benzinga Pro. However, earnings decreased 172.43%, resulting in a loss of $33.19 million.

Via Benzinga

What 7 Analyst Ratings Have To Say About JELD-WEN Holding ↗

October 12, 2022

Within the last quarter, JELD-WEN Holding (NYSE:JELD) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

Generac To Plunge 32%? Plus B of A Securities Cuts Price Target On JELD-WEN By 40% ↗

October 20, 2022

Roth Capital cut the price target on Generac Holdings Inc. (NYSE: GNRC) from $320 to $75. Generac shares dipped 25.3% to close at $110.30 on Wednesday.

Via Benzinga

Around $60 Million Bet On DICE Therapeutics? 3 Stocks Insiders Are Buying ↗

October 20, 2022

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Earnings Scheduled For October 31, 2022 ↗

October 31, 2022

Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

9 Industrials Stocks Moving In Monday's After-Market Session ↗

October 10, 2022

Gainers Greenwave Tech Solns (NASDAQ:GWAV) shares rose 5.4% to $1.37 during Monday's after-market session. The company's market cap stands at $14.0 million.

Via Benzinga

$2.3 Million Bet On JELD-WEN? 3 Stocks Insiders Are Buying ↗

October 10, 2022

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.